Manuel Sánchez-García
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Manuel Sánchez-García has a total of 129 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Gómez-Caamaño
Instituto de Investigación Sanitaria de Santiago de Compostela, Santiago de Compostela, Spain
4 shared publications - Juan Pardo-Montero
Group of Medical Physics and Biomathematics, Instituto de Investigación Sanitaria de Santiago (IDIS), 15706 Santiago de Compostela, Spain
4 shared publications - Laura Fachal
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, UK
4 shared publications Rachida Lebtahi
4 shared publicationsRamón Lobato-Busto
Department of Medical Physics, USC University Hospital Complex, SERGAS, Santiago de Compostela, Spain
4 shared publicationsAna Vega
1] Fundación Pública Galega de Medicina Xenómica, Servizo Galego de Saúde (SERGAS), Santiago de Compostela, Spain. [2] Grupo de Medicina Xenómica, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidade de Santiago de Compostela (USC), Santiago de Compostela, Spain
3 shared publications
Latest Publications
- Open Access
- 29 December 2025
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 57, 101101
Mini-GRID enhances survival and reduces toxicity in an orthotopic murine model of oral squamous cell carcinoma: A proof-of-concept study
- 29 December 2025
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 57, 101101
Open AccessMini-GRID enhances survival and reduces toxicity in an orthotopic murine model of oral squamous cell carcinoma: A proof-of-concept study
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S1966-S1968
PO-2183 Evaluation of MOSFET response in phantom for in vivo dosimetry in high-rate brachy breast treatments
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S1966-S1968
PO-2183 Evaluation of MOSFET response in phantom for in vivo dosimetry in high-rate brachy breast treatments
- Open Access
- 23 December 2020
- Published by Springer Nature in European Radiology
- Vol. 31 (6) , 4412
Correction to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?
- 23 December 2020
- Published by Springer Nature in European Radiology
- Vol. 31 (6) , 4412
Open AccessCorrection to: Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?
- Top Cited Papers
- 1 September 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (3) , 673-684
Relationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study
Higher tumor radiation–absorbed dose according to technetium 99m macroaggregated human albumin SPECT/CT was associated with better survival and tumor response in hepatocellular carcinoma treated wi... Background Little is known about factors that influence the efficacy of transarterial radioembolization (TARE). Purpose To determine the relationship between tumor radiation–absorbed dose and survi...
- 1 September 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 296 (3) , 673-684
Top Cited PapersRelationship of Tumor Radiation–absorbed Dose to Survival and Response in Hepatocellular Carcinoma Treated with Transarterial Radioembolization with 90Y in the SARAH Study
Higher tumor radiation–absorbed dose according to technetium 99m macroaggregated human albumin SPECT/CT was associated with better survival and tumor response in hepatocellular carcinoma treated wi... Background Little is known about factors that influence the efficacy of transarterial radioembolization (TARE). Purpose To determine the relationship between tumor radiation–absorbed dose and survi...
- 6 November 2018
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 38 (4) , 1501-1511
Adaptive biokinetic modelling of iodine-131 in thyroid cancer treatments: implications on individualised internal dosimetry
Nowadays therapies involving radioiodine (I-131) represent 84% of the total metabolic treatments in Europe, according to the last report of the European Association of Nuclear Medicine in relation to treatment planning for molecular radiotherapy. Last recommendations of the European Council, i.e. 2013/59/Euroatom, mandates that metabolic treatments should be planned according to the radiation doses delivered to individual patients, analogous to external beam radiotherapy. In this work, we present a novel biokinetic model for I-131 that allows on to obtain realistic activity distributions for particular patients with thyroid cancer in absence of metastasis. Other models existing in the literature present either a too simple metabolic description to obtain realistic results or a too complex one for adapting the model to individual patients, and many of these models are not indicated for metabolic treatments. The individualisation of activity distribution is obtained by an optimisation method that adjusts our model to a set of experimental measurements. Significant differences in terms of absorbed doses are observed between our model and the standard generalist models, especially in terms of red marrow absorbed dose.
- 6 November 2018
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 38 (4) , 1501-1511
Adaptive biokinetic modelling of iodine-131 in thyroid cancer treatments: implications on individualised internal dosimetry
Nowadays therapies involving radioiodine (I-131) represent 84% of the total metabolic treatments in Europe, according to the last report of the European Association of Nuclear Medicine in relation to treatment planning for molecular radiotherapy. Last recommendations of the European Council, i.e. 2013/59/Euroatom, mandates that metabolic treatments should be planned according to the radiation doses delivered to individual patients, analogous to external beam radiotherapy. In this work, we present a novel biokinetic model for I-131 that allows on to obtain realistic activity distributions for particular patients with thyroid cancer in absence of metastasis. Other models existing in the literature present either a too simple metabolic description to obtain realistic results or a too complex one for adapting the model to individual patients, and many of these models are not indicated for metabolic treatments. The individualisation of activity distribution is obtained by an optimisation method that adjusts our model to a set of experimental measurements. Significant differences in terms of absorbed doses are observed between our model and the standard generalist models, especially in terms of red marrow absorbed dose.
- 8 July 2016
- Published by Springer Nature in Clinical and Translational Imaging
- Vol. 4 (4) , 273-282
Absorbed-dose calculation for treatment of liver neoplasms with 90Y-microspheres
- 8 July 2016
- Published by Springer Nature in Clinical and Translational Imaging
- Vol. 4 (4) , 273-282
Absorbed-dose calculation for treatment of liver neoplasms with 90Y-microspheres
- 16 May 2016
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 36 (2) , 299-308
Evaluation and optimization of occupational eye lens dosimetry during positron emission tomography (PET) procedures
The last recommendations of the International Commission on Radiological Protection for eye lens dose suggest an important reduction on the radiation limits associated with early and late tissue reactions. The aim of this work is to quantify and optimize the eye lens dose associated to nurse staff during positron emission tomography (PET) procedures. PET is one of the most important diagnostic methods of oncological and neurological cancer disease involving an important number of workers exposed to the high energy isotope F-18. We characterize the relevant stages as preparation and administration of monodose syringes in terms of occupational dose. A direct reading silicon dosimeter was used to measure the lens dose to staff. The highest dose of radiation was observed during preparation of the fluorodesoxyglucose (FDG) syringes. By optimizing a suitable vials' distribution of FDG we find an important reduction in occupational doses. Extrapolation of our data to other clinical scenarios indicates that, depending on the work load and/or syringes activity, safety limits of the dose might be exceeded.
- 16 May 2016
- Published by IOP Publishing in Journal of Radiological Protection
- Vol. 36 (2) , 299-308
Evaluation and optimization of occupational eye lens dosimetry during positron emission tomography (PET) procedures
The last recommendations of the International Commission on Radiological Protection for eye lens dose suggest an important reduction on the radiation limits associated with early and late tissue reactions. The aim of this work is to quantify and optimize the eye lens dose associated to nurse staff during positron emission tomography (PET) procedures. PET is one of the most important diagnostic methods of oncological and neurological cancer disease involving an important number of workers exposed to the high energy isotope F-18. We characterize the relevant stages as preparation and administration of monodose syringes in terms of occupational dose. A direct reading silicon dosimeter was used to measure the lens dose to staff. The highest dose of radiation was observed during preparation of the fluorodesoxyglucose (FDG) syringes. By optimizing a suitable vials' distribution of FDG we find an important reduction in occupational doses. Extrapolation of our data to other clinical scenarios indicates that, depending on the work load and/or syringes activity, safety limits of the dose might be exceeded.
- 3 February 2016
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 173 (4) , ncv554-307
DEVELOPMENT AND IMPLEMENTATION OF TOOLS FOR SELF-MONITORING OF STAFF EXPOSED TO131I IN NUCLEAR MEDICINE CENTRES OF CHILE
Currently in Chile, there are about 42 nuclear medicine centres that mainly use 99mTc and 131I in diagnostic and therapeutic procedures. Therefore, staff performs various tasks that increase the risk of internal incorporation and the need to implement routine monitoring programmes. This article shows tools for self-monitoring of staff who exposed to 131I from measurements in thyroid and urine samples, using the gamma cameras of Nuclear Medicine Units. Then, the calibration factors of gamma cameras of participating units were determined, and a one-worker dose was calculated due to internal incorporation, using an Excel spreadsheet for self-monitoring. The worker who handles 131I in one of the studied units was monitored for 6 months. The goal of this study is to implement a routine self-monitoring programme for the estimation of committed effective dose of staff exposed to 131I using gamma cameras in Nuclear Medicine Units of clinical centres in Chile.
- 3 February 2016
- Published by Oxford University Press (OUP) in Radiation Protection Dosimetry
- Vol. 173 (4) , ncv554-307
DEVELOPMENT AND IMPLEMENTATION OF TOOLS FOR SELF-MONITORING OF STAFF EXPOSED TO131I IN NUCLEAR MEDICINE CENTRES OF CHILE
Currently in Chile, there are about 42 nuclear medicine centres that mainly use 99mTc and 131I in diagnostic and therapeutic procedures. Therefore, staff performs various tasks that increase the risk of internal incorporation and the need to implement routine monitoring programmes. This article shows tools for self-monitoring of staff who exposed to 131I from measurements in thyroid and urine samples, using the gamma cameras of Nuclear Medicine Units. Then, the calibration factors of gamma cameras of participating units were determined, and a one-worker dose was calculated due to internal incorporation, using an Excel spreadsheet for self-monitoring. The worker who handles 131I in one of the studied units was monitored for 6 months. The goal of this study is to implement a routine self-monitoring programme for the estimation of committed effective dose of staff exposed to 131I using gamma cameras in Nuclear Medicine Units of clinical centres in Chile.
- 25 September 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (20) , 7861-7876
Implementation and validation of collapsed cone superposition for radiopharmaceutical dosimetry of photon emitters
Two collapsed cone (CC) superposition algorithms have been implemented for radiopharmaceutical dosimetry of photon emitters. The straight CC (SCC) superposition method uses a water energy deposition kernel (EDKw) for each electron, positron and photon components, while the primary and scatter CC (PSCC) superposition method uses different EDKw for primary and once-scattered photons. PSCC was implemented only for photons originating from the nucleus, precluding its application to positron emitters. EDKw are linearly scaled by radiological distance, taking into account tissue density heterogeneities. The implementation was tested on 100, 300 and 600 keV mono-energetic photons and 18F, 99mTc, 131I and 177Lu. The kernels were generated using the Monte Carlo codes MCNP and EGSnrc. The validation was performed on 6 phantoms representing interfaces between soft-tissues, lung and bone. The figures of merit were γ (3%, 3 mm) and γ (5%, 5 mm) criterions corresponding to the computation comparison on 80 absorbed doses (AD) points per phantom between Monte Carlo simulations and CC algorithms. PSCC gave better results than SCC for the lowest photon energy (100 keV). For the 3 isotopes computed with PSCC, the percentage of AD points satisfying the γ (5%, 5 mm) criterion was always over 99%. A still good but worse result was found with SCC, since at least 97% of AD-values verified the γ (5%, 5 mm) criterion, except a value of 57% for the 99mTc with the lung/bone interface. The CC superposition method for radiopharmaceutical dosimetry is a good alternative to Monte Carlo simulations while reducing computation complexity.
- 25 September 2015
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 60 (20) , 7861-7876
Implementation and validation of collapsed cone superposition for radiopharmaceutical dosimetry of photon emitters
Two collapsed cone (CC) superposition algorithms have been implemented for radiopharmaceutical dosimetry of photon emitters. The straight CC (SCC) superposition method uses a water energy deposition kernel (EDKw) for each electron, positron and photon components, while the primary and scatter CC (PSCC) superposition method uses different EDKw for primary and once-scattered photons. PSCC was implemented only for photons originating from the nucleus, precluding its application to positron emitters. EDKw are linearly scaled by radiological distance, taking into account tissue density heterogeneities. The implementation was tested on 100, 300 and 600 keV mono-energetic photons and 18F, 99mTc, 131I and 177Lu. The kernels were generated using the Monte Carlo codes MCNP and EGSnrc. The validation was performed on 6 phantoms representing interfaces between soft-tissues, lung and bone. The figures of merit were γ (3%, 3 mm) and γ (5%, 5 mm) criterions corresponding to the computation comparison on 80 absorbed doses (AD) points per phantom between Monte Carlo simulations and CC algorithms. PSCC gave better results than SCC for the lowest photon energy (100 keV). For the 3 isotopes computed with PSCC, the percentage of AD points satisfying the γ (5%, 5 mm) criterion was always over 99%. A still good but worse result was found with SCC, since at least 97% of AD-values verified the γ (5%, 5 mm) criterion, except a value of 57% for the 99mTc with the lung/bone interface. The CC superposition method for radiopharmaceutical dosimetry is a good alternative to Monte Carlo simulations while reducing computation complexity.
- 1 December 2014
- Published by Elsevier in Physica Medica
- Vol. 30, e134
Implementation and validation of the «collapsed cone» superposition principle in internal dosimetry for Yttrium 90 therapy
- 1 December 2014
- Published by Elsevier in Physica Medica
- Vol. 30, e134
Implementation and validation of the «collapsed cone» superposition principle in internal dosimetry for Yttrium 90 therapy